QLYSQualys, Inc.

$202.41+49% 1Y
Latest close: a new 52-week highOct 9, 2026what changed →

Is the business good?

Excellent

A genuinely good business: 7 of 9 health tests passed, earnings fully cash-backed (1.7×), and margins widening.

4 good
Fundamental health (F-score)7 / 9SEC EDGAR · Dec 31, 2025

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash1.68×derived · Jun 30, 2026

Operating profit is fully backed by cash. Conversion is improving vs a year ago.

Margin direction, 3 years+7.3 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from19% ROA

High-quality, exceptional returns on the assets themselves, not leverage. ROE 36% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbetter than 76% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is QLYS?

Qualys, Inc. earns 61% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

61%

Return on invested capital · cost of capital 9.0% · 52 points above what the capital costs: growth creates value

Operating margin
34%

Operating margin · Software - Infrastructure median 5.8% · 12 months to Q2 2026

Cash conversion
1.68×

Cash conversion · 1.54× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−4.1%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY202027%
FY202121%
FY202227%
FY202329%
FY202431%
FY202533%
Details›
Gross margin12 months to Q2 2026
83%
Operating margin12 months to Q2 2026
34%
Net margin12 months to Q2 2026
29%
Free cash flow margin
45%
R&D as % of revenue
17%
Revenue, trailing twelve months
$703M
Free cash flow, trailing twelve months
$314M
Net income, trailing twelve months
$207M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
61%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.